For knee arthritis, the research points to a dose in the billions: PRP arms with positive results averaged about 5.5 billion platelets per injection, and one meta-analysis puts the threshold above 10 billion. Arms without benefit averaged about 2.3 billion. A ‘times baseline’ figure describes concentration; the dose reviews count platelets. For tendons and other tissues the right dose is still unsettled, and we will tell you so.
If you have had PRP, you may not know what was in the syringe. In knee arthritis it is one of the variables the research ties to results, and you are allowed to ask for it.
What the dose research actually shows
The knee trials, sorted by dose
A 2025 systematic review in Arthroscopy grouped knee arthritis trials by the platelet dose they reported. The 28 of 31 PRP arms with positive six-month results averaged about 5.5 billion platelets; the three without averaged about 2.3 billion, and the gap held at twelve months. A 2024 meta-analysis in Current Reviews in Musculoskeletal Medicine placed the threshold for favorable results above 10 billion platelets, with the effect stronger for function than for pain. A 2026 meta-regression linked a higher platelet increase to better six-month results but called its findings hypothesis-generating. A 2025 meta-analysis of 18 placebo-controlled knee trials split PRP by concentration in platelets per microliter, not a times-baseline multiple, at about a million: the high-platelet products gave clinically meaningful pain relief at three, six and twelve months, and the low-platelet products did not. The limit: these reviews compare studies rather than testing doses head to head.
The 10 billion trial, read carefully
A 2021 randomized trial in Scientific Reports gave 150 patients with knee arthritis either PRP containing 10 billion platelets or hyaluronic acid, and followed them for a year. Knee scores and the distance walked without pain stayed significantly better in the PRP group at one year. The authors concluded that 10 billion is crucial. The design is narrower than that: one PRP dose against a different injection, not a high dose against a low one. It shows 10 billion worked; on its own it cannot show that less would fail.
The negative trial, and the number it leaves out
The negative trial to know is RESTORE, published in JAMA in 2021. It gave 288 people with mild to moderate knee arthritis three weekly injections of a commercial leukocyte-poor PRP or saline, blinded for participants, injectors and assessors, and at twelve months pain and cartilage volume did not differ. It counts. Its abstract does not report how many platelets each injection held, which is the number the dose reviews link to results. That is why we compare doses, not labels, and why not all PRP is the same.
Beyond the count: tissue, leukocytes and handling
For tendons and other tissues, the 2024 review found a lower dose may suffice but called the literature unclear. Leukocytes are a separate question with mixed answers: a 2021 meta-analysis favored leukocyte-poor PRP on one knee score, while a 2024 double-blind trial of 132 patients found no difference. A 2025 review adds that red cell contamination and pre-activation appear to work against PRP. Count first, recipe second. See how we build it on PRP therapy, and how dose separates products in high-dose PRP versus standard PRP.
Signs you are buying a label, not a dose
None of these means an injection will fail. Each one means you do not know what you are getting.
- The clinic can quote a ‘times baseline’ figure but not a platelet count
- One preparation is split across several sites, so each gets a fraction
- A series of injections is sold before the first has been judged
- Nobody can say who places the needle, or whether imaging guides it
- The price comes up before the preparation does
Before you book, ask
- How many platelets, in billions, will be in my injection?
- Is it leukocyte-rich or leukocyte-poor, and why for my tissue?
- Who places it, and is it guided by live ultrasound?
Why dose is a time question
An under-dosed injection costs more than its price. It costs the weeks you wait to learn it did little, and the weeks after that. Getting the dose right the first time is how you buy that time back.
Frequently asked questions
How many platelets should a PRP injection have?
For knee arthritis, the best current answer is several billion at least, and more may be better. A 2025 systematic review of knee trials that reported platelet dose found the 28 of 31 PRP arms with positive results averaged about 5.5 billion platelets per injection, against about 2.3 billion in the three without benefit. A 2024 meta-analysis put the threshold for favorable results above 10 billion, and a 2025 narrative review suggested over 3.5 billion per injection. For tendons and other tissues the right number is not yet clear. Dynamic PRP+ delivers over 10 billion platelets.
What is the difference between PRP concentration and PRP dose?
Concentration is how much richer in platelets the PRP is than your blood, usually written as a multiple of baseline. Dose is the number of platelets actually injected, which depends on both the concentration and the volume. The dose reviews for knee arthritis count platelets in billions, so a high multiple in a small volume can still be a modest dose. Ask for both numbers. Dynamic PRP+ is concentrated 12 to 20 times baseline and delivers over 10 billion platelets.
Is 10 billion platelets the right PRP dose?
It is the highest threshold proposed in the reviews we read, not a settled standard. A 2024 meta-analysis identified a threshold above 10 billion platelets for favorable results in knee arthritis, and a 2021 randomized trial that used 10 billion platelets found benefits over hyaluronic acid that lasted a year. That trial did not test lower doses, so it cannot show that less fails. Another review suggested over 3.5 billion per injection. Dynamic PRP+ is built to clear the highest of these thresholds.
Is high-dose PRP better for tendons?
Not clearly, and we will not pretend otherwise. The 2024 dose meta-analysis found the dose link clearest in knee arthritis and said a lower dose may suffice for other conditions, while noting the literature lacks clarity. For tendons, preparation and placement also matter: a 2017 meta-analysis of 18 trials found the strongest results with leukocyte-rich PRP and good evidence for a single injection under ultrasound guidance. We set the protocol to the tissue rather than using one number for everything.
Does double-spin PRP mean a higher dose?
Not by itself. Spinning is a method; the platelet count is the result. In a 2026 randomized trial of 45 people with knee arthritis in three groups, single-spun and double-spun PRP gave comparable results, and its abstract reports no platelet counts, so it cannot say which delivered more. Our Dynamic PRP+ uses multi-spin processing, but the number that matters is what it produces: platelets concentrated 12 to 20 times baseline, over 10 billion. Ask any clinic for the count, not the number of spins.
Should PRP be leukocyte-rich or leukocyte-poor?
For knee arthritis the evidence is mixed. A 2021 meta-analysis of 18 randomized trials found leukocyte-poor PRP associated with better scores on one knee measure, while a 2024 double-blind trial of 132 patients comparing the two directly found no difference in results or side effects over twelve months. For tendons, a 2017 meta-analysis found the strongest effects with leukocyte-rich preparations. So the answer depends on the tissue, and it is a separate question from the platelet count.
Why did a large trial find PRP did not work for knee arthritis?
That is the RESTORE trial, published in JAMA in 2021. It gave 288 people with mild to moderate knee arthritis three weekly injections of a commercial leukocyte-poor PRP or saline, and found no difference in pain or cartilage volume at twelve months. It was a carefully blinded trial and it should be taken seriously. Its abstract does not report the platelet dose, so it cannot tell us whether a higher dose would have changed the result. The dose-sorted reviews suggest it might.
How do I find out the PRP dose a clinic uses?
Ask for the platelet count per injection, in billions, not just the concentration. Ask whether one preparation is split across several sites, because that divides the dose. Ask whether it is leukocyte-rich or leukocyte-poor and why for your tissue, and who places it under what guidance. A clinic that answers plainly has thought about it. Dynamic PRP+ delivers over 10 billion platelets, 12 to 20 times baseline, placed under live ultrasound by Aneesh Garg, DO, CAQ.
Know what is in your syringe
Book an evaluation with Aneesh Garg, DO, CAQ. He examines the problem, reviews your imaging and explains the dose he would use and why. Every Dynamic PRP+ injection is performed by him under live ultrasound.
Book an Evaluation
1790 30th Street Suite 270 · Boulder, CO 80301 · 303-997-1733